Bose R, Ekramoddoullah A K, Kisil F T, Sehon A H
Department of Immunology, Faculty of Medicine, University of Manitoba, Winnipeg, Canada.
Immunology. 1988 Apr;63(4):579-84.
The possibility that a murine monoclonal antibody (mAb 12) to Rye grass pollen allergen LolpIV and LolpIV-specific antibodies in the sera of grass allergic individuals share a common idiotope (Id) was investigated. It was first established that mAb 12 and human IgE antibodies recognized the same (or similar) epitope(s) on LolpIV; i.e. mAb 12 could inhibit, to the extent of 35-60%, the binding of 125I-LolpIV to the human IgE antibodies present in the sera of grass pollen-allergic individuals. Subsequently, a rabbit anti-Id antiserum was produced against mAb 12 and rendered Id-specific by appropriate immune absorptions, and its IgG antibody fraction was isolated (Rb-aId). The specificity of Rb-aId was demonstrated by the fact that the antibodies bound only to mAb 12 and not to any other murine monoclonal antibody tested. Observations that Rb-aId inhibited the binding of 125I-LolpIV to mAb 12 indicated that the Id determinants recognized on mAb 12 were located at or near the antibody-combining sites. The Rb-aId also bound specifically to affinity-purified human anti-LolpIV antibodies isolated from human sera, but not to affinity-purified human anti-tetanus toxoid antibodies. This indicated that the human anti-LolpIV antibodies share a cross-reactive Id. The binding of Rb-aId to human anti-LolpIV antibody could also be inhibited by mAb 12. Therefore, it was concluded that the murine and human antibodies to LolpIV share a cross-reactive idiotope.
研究了针对黑麦草花粉变应原LolpIV的鼠单克隆抗体(mAb 12)与草过敏个体血清中LolpIV特异性抗体是否具有共同独特型(Id)的可能性。首先确定mAb 12和人IgE抗体识别LolpIV上相同(或相似)的表位;即mAb 12可抑制125I-LolpIV与草花粉过敏个体血清中存在的人IgE抗体的结合,抑制程度为35%-60%。随后,制备了针对mAb 12的兔抗独特型抗血清,并通过适当的免疫吸附使其具有独特型特异性,然后分离出其IgG抗体部分(Rb-aId)。Rb-aId的特异性通过以下事实得以证明:这些抗体仅与mAb 12结合,而不与任何其他测试的鼠单克隆抗体结合。观察到Rb-aId抑制125I-LolpIV与mAb 12的结合,表明在mAb 12上识别的独特型决定簇位于抗体结合位点处或附近。Rb-aId还特异性结合从人血清中分离的亲和纯化的人抗LolpIV抗体,但不结合亲和纯化的人抗破伤风类毒素抗体。这表明人抗LolpIV抗体具有交叉反应性独特型。Rb-aId与人抗LolpIV抗体的结合也可被mAb 12抑制。因此,得出结论:针对LolpIV的鼠抗体和人抗体具有交叉反应性独特型。